Institutions / Seven Fleet Capital Management LP
Seven Fleet Capital Management LP
CIK 2092021 · Institution · as of Dec 31, 2025
Portfolio value
$131.48M
Positions
85
As of
Dec 31, 2025
Top holdings
Dec 31, 2025View all 85 →
| Company | Value | % of portfolio |
|---|---|---|
| CG Oncology, Inc. | $62.91M | 47.8% |
| Soleno Therapeutics, Inc. | $6.02M | 4.6% |
| Revolution Medicines, Inc. | $5.24M | 4.0% |
| Liquidia CorpLQDA | $3.15M | 2.4% |
| Compass Therapeutics, Inc. | $3.05M | 2.3% |
| Exelixis, Inc. | $3.01M | 2.3% |
| Axsome Therapeutics, Inc. | $2.37M | 1.8% |
| Tyra Biosciences, Inc. | $2.09M | 1.6% |
| Cogent Biosciences, Inc. | $1.92M | 1.5% |
| Tango Therapeutics, Inc. | $1.91M | 1.4% |
| Xencor Inc | $1.68M | 1.3% |
| Pharvaris N.V. | $1.54M | 1.2% |
| Terns Pharmaceuticals, Inc. | $1.49M | 1.1% |
| Belite Bio, IncBLTE | $1.47M | 1.1% |
| Dyne Therapeutics, Inc. | $1.37M | 1.0% |
| Nuvalent, Inc. | $1.27M | 1.0% |
| Ascendis Pharma A/S | $1.21M | 0.9% |
| Amicus Therapeutics Inc | $1.17M | 0.9% |
| Vaxcyte, Inc. | $1.17M | 0.9% |
| Avalo Therapeutics, Inc. | $1.15M | 0.9% |
| Inhibikase Therapeutics, Inc. | $1.09M | 0.8% |
| Madrigal Pharmaceuticals, Inc. | $1.08M | 0.8% |
| Geron Corp | $1.03M | 0.8% |
| Krystal Biotech, Inc. | $986.2K | 0.8% |
| LeonaBio, Inc.LONA | $968.6K | 0.7% |
Activity
Dec 31, 2025
InsidersInstitutions
This fund's 13F position changes — what it's buying and selling.No quarter-over-quarter changes yet — position changes appear once we've ingested two consecutive 13F filings for this manager. We currently hold 1 quarter of holdings.